CFO Rachid Ayari to step down on 30 September 2026

Cfo ResignedManagement Changes View source PDF Explain this filing

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹3412.00

prior close

₹3405.10

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.7%+0.3% vs market

Pharmaceuticals peers, median of 164sector-0.7%+0.3% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.1

15m

+0.1

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4-0.7+0.3-0.7+0.3

Next day

-0.3-0.3-0.0-0.8+0.6

-1.2+1.1-2.3-0.1-1.1

-1.4-0.2-1.1-0.7-0.6

+0.2+0.2-0.0+0.0+0.2

-1.4-0.3-1.1-0.6-0.9

-0.5+2.1-2.6-0.2-0.3

15d

-4.9+4.6-9.5+2.4-7.4

-4.4+5.6-10.0+1.0-5.4

-10.4+7.2-17.6+4.0-14.4

-18.7-4.7-14.0-5.5-13.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Rachid Ayari, Whole Time Director, CFO and Key Managerial Personnel of Sanofi India, will step down effective close of business on 30 September 2026 to take up another role within the Sanofi group. He also ceases to be a member of the Risk Management Committee. The company is in the process of identifying a suitable candidate as the new CFO and will inform the exchanges of the appointment in due course.

Likely market impact

Planned internal transition within Sanofi group; successor search underway. Watch for the new CFO appointment announcement and continuity of financial reporting.